Search

Ferroptosis is a recently discovered special type of regulated cell death that is strongly associated with both homeostasis maintenance and cancer development. Previous studies have indicated that a number of small-molecular agents inducing ferroptosis have great potential in the treatment of different types of cancer, including breast, pancreatic, prostate and head and neck cancer. However, the role of ferroptosis in nasopharyngeal carcinoma (NPC) has remained to be fully determined. To the best of our knowledge, no review of the currently available studies on this subject has been published to date. The metabolism and expression of specific genes that regulate ferroptosis may represent a promising radiosensitization target in cancer treatment. The aim of the present review was to describe the cross-link between ferroptosis and NPC and to discuss the potential value of regulators and the possible mechanism underlying the role of ferroptosis in the radiosensitization of NPC, in the hope that linking the mechanism of ferroptosis with the development of NPC will accelerate the development of novel ferroptosis-based targets and radiotherapy strategies in NPC. [ABSTRACT FROM AUTHOR]

[Display omitted] Immobilizing catalyst system faces the challenge of balancing catalysts stability and exposure of active site in water treatment. In this study, a novel in-situ synthesis of monoclinic phase of titanium dioxide (TiO 2 (B)) in cellulose-derived carbon aerogel (TCA) is proposed for processing multi-task in water treatment. The homogeneous gelation reaction supported the high dispersion of TiO 2 (B) in carbon skeleton. Meanwhile, TiO 2 acts as crosslinker to reinforce cellulose network, then the grain refinement of amorphous TiO 2 is limited to obtain TiO 2 (B) during carbonization. Benefiting from the reinforced structure, TCA remains the porous structure after carbonization and exposes more adsorption site than carbon aerogel blended with anatase particles (ACA). The adsorption performance of TCA are 837.3 mg/g, 1156.2 mg/g and 512.6 mg/g on methylene blue, malachite green and crystal violet, respectively. Compared with ACA, the superior interaction between TiO 2 and graphite-like carbon improves the degradation rate of tetracycline from 1.3 × 10–3 min−1 to 8.6 × 10–3 min−1, and maintains the degradation efficiency in 3 rounds cyclic test. Besides, TCA also exhibits nearly twice to ACA on absorption capacity of different oil. This facile in-situ synthesis method offers a new insight in fabricating carbon aerogel immobilized photocatalysts system for multi-task in water treatment. [ABSTRACT FROM AUTHOR]

[Display omitted] Immobilizing catalyst system faces the challenge of balancing catalysts stability and exposure of active site in water treatment. In this study, a novel in-situ synthesis of monoclinic phase of titanium dioxide (TiO 2 (B)) in cellulose-derived carbon aerogel (TCA) is proposed for processing multi-task in water treatment. The homogeneous gelation reaction supported the high dispersion of TiO 2 (B) in carbon skeleton. Meanwhile, TiO 2 acts as crosslinker to reinforce cellulose network, then the grain refinement of amorphous TiO 2 is limited to obtain TiO 2 (B) during carbonization. Benefiting from the reinforced structure, TCA remains the porous structure after carbonization and exposes more adsorption site than carbon aerogel blended with anatase particles (ACA). The adsorption performance of TCA are 837.3 mg/g, 1156.2 mg/g and 512.6 mg/g on methylene blue, malachite green and crystal violet, respectively. Compared with ACA, the superior interaction between TiO 2 and graphite-like carbon improves the degradation rate of tetracycline from 1.3 × 10–3 min−1 to 8.6 × 10–3 min−1, and maintains the degradation efficiency in 3 rounds cyclic test. Besides, TCA also exhibits nearly twice to ACA on absorption capacity of different oil. This facile in-situ synthesis method offers a new insight in fabricating carbon aerogel immobilized photocatalysts system for multi-task in water treatment. [ABSTRACT FROM AUTHOR]

Aim and Objective. Hyperlipidemia is a public health matter of global scale, contributing to a wide range of diseases that can result in severe complications and significant annual mortality. Dendrobium officinale (DO) is an edible plant with a long medicinal history in China. Our previous studies revealed that DO may have therapeutic benefits in lipid disorders. However, the mechanism of its active compounds is still unclear. This research aimed at uncovering the hidden anti-hyperlipidemia mechanisms of DO through network pharmacology and experimental validation. Materials and Methods. The active compounds in DO, their targets, and targets associated with hyperlipidemia were screened across various databases, and the hidden targets of DO in treating hyperlipidemia were forecast. The compound-target (C-T), protein-protein interaction (PPI), and compound-target-pathway (C-T-P) networks of DO were set up with Cytoscape software. The hub genes and core clusters of DO predicted to be active against hyperlipidemia were calculated by Cytoscape. The DAVID database was adopted for Gene Ontology (GO) analysis and KEGG pathway enrichment analysis. Next, we used the high-sucrose-fat diet and alcohol (HFDA)-induced hyperlipidemia rats to evaluate the hypolipidemic effect of DO. Results. In this study, we obtained 264 compounds from DO, revealed 11 bioactive compounds, and predicted 89 potential targets of DO. The network analysis uncovered that naringenin, isorhamnetin, and taxifolin might be the compounds in DO that are mainly in charge of its roles in hyperlipidemia and might play a role by modulating the targets (including PPARG, ADIPOQ, AKT1, TNF, and APOB). The pathway analysis showed that DO might affect diverse signaling pathways related to the pathogenesis of hyperlipidemia, including PPAR signaling pathway, insulin resistance, AMPK signaling pathway, and non-alcoholic fatty liver disease simultaneously. Meanwhile, in the HFDA-induced hyperlipidemia rat model, DO could significantly decrease the level of TC, TG, LDL-c, and ALT in serum, and increase HDL-c as well. The liver pathological section indicated that DO could ease liver damage and lipid cumulation. Conclusion. In summary, the biological targets of the main bioactive compounds in DO were found to distribute across multiple metabolic pathways. These findings suggest that a mutual regulatory system consisting of multiple components, targets, and pathways is a likely mechanism through which DO may improve hyperlipidemia. Validation experiments indicated that DO may treat hyperlipidemia by affecting NAFLD-related signaling pathways. [ABSTRACT FROM AUTHOR]

Aim and Objective. Hyperlipidemia is a public health matter of global scale, contributing to a wide range of diseases that can result in severe complications and significant annual mortality. Dendrobium officinale (DO) is an edible plant with a long medicinal history in China. Our previous studies revealed that DO may have therapeutic benefits in lipid disorders. However, the mechanism of its active compounds is still unclear. This research aimed at uncovering the hidden anti-hyperlipidemia mechanisms of DO through network pharmacology and experimental validation. Materials and Methods. The active compounds in DO, their targets, and targets associated with hyperlipidemia were screened across various databases, and the hidden targets of DO in treating hyperlipidemia were forecast. The compound-target (C-T), protein-protein interaction (PPI), and compound-target-pathway (C-T-P) networks of DO were set up with Cytoscape software. The hub genes and core clusters of DO predicted to be active against hyperlipidemia were calculated by Cytoscape. The DAVID database was adopted for Gene Ontology (GO) analysis and KEGG pathway enrichment analysis. Next, we used the high-sucrose-fat diet and alcohol (HFDA)-induced hyperlipidemia rats to evaluate the hypolipidemic effect of DO. Results. In this study, we obtained 264 compounds from DO, revealed 11 bioactive compounds, and predicted 89 potential targets of DO. The network analysis uncovered that naringenin, isorhamnetin, and taxifolin might be the compounds in DO that are mainly in charge of its roles in hyperlipidemia and might play a role by modulating the targets (including PPARG, ADIPOQ, AKT1, TNF, and APOB). The pathway analysis showed that DO might affect diverse signaling pathways related to the pathogenesis of hyperlipidemia, including PPAR signaling pathway, insulin resistance, AMPK signaling pathway, and non-alcoholic fatty liver disease simultaneously. Meanwhile, in the HFDA-induced hyperlipidemia rat model, DO could significantly decrease the level of TC, TG, LDL-c, and ALT in serum, and increase HDL-c as well. The liver pathological section indicated that DO could ease liver damage and lipid cumulation. Conclusion. In summary, the biological targets of the main bioactive compounds in DO were found to distribute across multiple metabolic pathways. These findings suggest that a mutual regulatory system consisting of multiple components, targets, and pathways is a likely mechanism through which DO may improve hyperlipidemia. Validation experiments indicated that DO may treat hyperlipidemia by affecting NAFLD-related signaling pathways. [ABSTRACT FROM AUTHOR]